Cargando…

Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results

To avoid potentially severe outcomes, phenylketonuria (PKU) must be detected as soon as possible after birth and managed with life-long treatment. A questionnaire-based survey was performed to document diagnosis and management practices for PKU in a region of Southern and Eastern Europe. Prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giżewska, Maria, MacDonald, Anita, Bélanger-Quintana, Amaya, Burlina, Alberto, Cleary, Maureen, Coşkun, Turgay, Feillet, François, Muntau, Ania C., Trefz, Friedrich K., van Spronsen, Francjan J., Blau, Nenad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724370/ https://www.ncbi.nlm.nih.gov/pubmed/26350228 http://dx.doi.org/10.1007/s00431-015-2622-5

Ejemplares similares

The complete European guidelines on phenylketonuria: diagnosis and treatment
por: van Wegberg, A. M. J., et al.
Publicado: (2017)

Correction to: PKU dietary handbook to accompany PKU guidelines
por: MacDonald, A., et al.
Publicado: (2020)

PKU dietary handbook to accompany PKU guidelines
por: MacDonald, A., et al.
Publicado: (2020)

Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria
por: MacDonald, Anita, et al.
Publicado: (2018)

Sleep Disturbances in Phenylketonuria: An Explorative Study in Men and Mice
por: Bruinenberg, Vibeke M., et al.
Publicado: (2017)

Bone mineral density is within normal range in most adult phenylketonuria patients
por: Lubout, Charlotte M. A., et al.
Publicado: (2020)

Nitrogen Balance after the Administration of a Prolonged-Release Protein Substitute for Phenylketonuria as a Single Dose in Healthy Volunteers
por: Scheinin, Mika, et al.
Publicado: (2021)

Health economic burden of patients with phenylketonuria (PKU) – A retrospective study of German health insurance claims data
por: Trefz, Friedrich, et al.
Publicado: (2021)

When should social service referral be considered in phenylketonuria?
por: van Rijn, Margreet, et al.
Publicado: (2015)

Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial
por: Muntau, Ania C., et al.
Publicado: (2021)

Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype
por: Anjema, Karen, et al.
Publicado: (2013)

Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis
por: Ilgaz, Fatma, et al.
Publicado: (2019)

Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria
por: Pinto, Alex, et al.
Publicado: (2019)

Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase
por: Rocha, Júlio César, et al.
Publicado: (2021)

Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile
por: Pena, Maria João, et al.
Publicado: (2015)

Characterisation and differential diagnosis of neurological complications in adults with phenylketonuria: literature review and expert opinion
por: Merkel, Martin, et al.
Publicado: (2023)

The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?
por: Anjema, Karen, et al.
Publicado: (2016)

Diagnostic and therapeutic recommendations for the treatment of hyperphenylalaninemia in patients 0–4 years of age
por: Muntau, Ania C., et al.
Publicado: (2018)

Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis
por: de Groot, Martijn J, et al.
Publicado: (2013)

The Behavioral Consequence of Phenylketonuria in Mice Depends on the Genetic Background
por: Bruinenberg, Vibeke M., et al.
Publicado: (2016)

Acute exercise in treated phenylketonuria patients: Physical activity and biochemical response
por: Mazzola, Priscila Nicolao, et al.
Publicado: (2015)

Gut-Microbiome Composition in Response to Phenylketonuria Depends on Dietary Phenylalanine in BTBR Pah(enu2) Mice
por: van der Goot, Els, et al.
Publicado: (2022)

Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life
por: ten Hoedt, Amber E., et al.
Publicado: (2011)

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

New challenges in management of phenylketonuria in pregnancy: a case report
por: Ugalde-Abiega, Beatriz, et al.
Publicado: (2023)

Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU)
por: Bruinenberg, Vibeke M., et al.
Publicado: (2019)

Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria
por: Rocha, Júlio César, et al.
Publicado: (2023)

Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data
por: Trefz, K. F., et al.
Publicado: (2019)

Reproductive experience of women living with phenylketonuria
por: Ford, Suzanne, et al.
Publicado: (2018)

A Specific Nutrient Combination Attenuates the Reduced Expression of PSD-95 in the Proximal Dendrites of Hippocampal Cell Body Layers in a Mouse Model of Phenylketonuria
por: Bruinenberg, Vibeke M., et al.
Publicado: (2016)

Phenylketonuria (PKU) Urinary Metabolomic Phenotype Is Defined by Genotype and Metabolite Imbalance: Results in 51 Early Treated Patients Using Ex Vivo (1)H-NMR Analysis
por: Cannet, Claire, et al.
Publicado: (2023)

Dietary intervention in the management of phenylketonuria: current perspectives
por: Rocha, Júlio César, et al.
Publicado: (2016)

Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
por: Cazzorla, Chiara, et al.
Publicado: (2014)

Living with Phenylketonuria: Lessons from the PKU community
por: Ford, Suzanne, et al.
Publicado: (2018)

Living with phenylketonuria in adulthood: The PKU ATTITUDE study
por: Cazzorla, Chiara, et al.
Publicado: (2018)

Prescribing issues experienced by people living with phenylketonuria in the UK
por: Ford, Suzanne, et al.
Publicado: (2019)

The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria
por: Burlina, Alessandro P., et al.
Publicado: (2020)

Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries
por: Bosch, Annet M, et al.
Publicado: (2015)

Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients’ and parents’ quality of life: the phenylketonuria – quality of life (PKU-QOL) questionnaires
por: Regnault, Antoine, et al.
Publicado: (2015)

Mild hyperphenylalaninemia: to treat or not to treat
por: van Spronsen, Francjan J.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kqov8a2d2rtpfbnevi13ug38io